Drug Profile


Alternative Names: S-metoprolol extended release/clopidogrel immediate release - Emcure

Latest Information Update: 08 Sep 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Emcure Pharmaceuticals
  • Class Antihypertensives; Antiplatelets; Class II antiarrhythmics; Heart failure therapies; Ischaemic heart disorder therapies; Propanolamines; Pyridines; Small molecules; Thiophenes
  • Mechanism of Action Beta 1 adrenergic receptor antagonists; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Cardiovascular disorders; Hypertension; Thrombosis

Most Recent Events

  • 24 May 2010 Phase-III clinical trials in Cardiovascular disorders (prevention) in India (PO)
  • 24 May 2010 Phase-III clinical trials in Hypertension in India (PO)
  • 24 May 2010 Phase-III clinical trials in Thrombosis (prevention) in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top